Cipla

Rediff.com » News » Cipla

News for Cipla

News
Business

'14+ Anti-Obesity Drugs In The Pipeline'

The semaglutide patent expiry next year could unleash a wave of generic versions from Indian drugmakers, with prices expected to go lower -- at least 80 per cent. IMAGE: Pens for the diabetes drug......

Cipla ready to partner in Covid vaccine distribution

However, Cipla was very clear it does not want to get into vaccine manufacturing. Sohini Das reports. IMAGE: Healthcare workers wearing PPE kits carry syringes towards a Covid-19......

Cipla gets nod to import Moderna vaccine for emergency use in India

India's drug regulator Drugs Controller General of India has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna's COVID-19 vaccine for restricted emergency use in the......

Cipla to price Remdesivir for Covid-19 under Rs 5,000

Hetero has priced the injectable drug at Rs 5,400 per 100 mg vial. With more drugmakers in line to launch the drug soon, the prices may see a further erosion. Sohini Das reports. IMAGE: An......

Future Gaming tops electoral bonds list with Rs 1368 cr; who are the others?

Following are the top buyers of the scrapped electoral bonds, the data for which was released by the Election Commission on Thursday. Future Gaming and Hotel Services: Rs 1,368 crore Megha......

Cipla Q2 profit up 3.7% at Rs 1,353 cr

Pharma major Cipla Ltd on Thursday reported a 3.7 per cent rise in consolidated net profit at Rs 1,353.37 crore for the second quarter ended September 30, 2025. Photograph: Danish Siddiqui/Reuters......

Domestic sales a booster dose for pharma revenues

Buoyant domestic sales are expected to lift revenues for pharma companies by 8–11 per cent in Q3FY26, even as declining generic Revlimid (cancer drug) sales in the US remain a key drag.......

Weightloss Drugs Hit 1,000 Crore Mark

'As more patients are prescribed these drugs, intolerance due to gastrointestinal and other side effects will become more visible, leading to higher discontinuation rates.' IMAGE: A pharmacist......

USFDA's new draft biosimilar rules to benefit Indian biotech cos

The US Food and Drug Administration’s (USFDA)’s new draft guidelines aimed at speeding up and reducing the cost of developing biosimilars — lower-priced, near-replicas of complex biologic......

Cipla Q4 profit up 30% at Rs 1,222 cr

Drug major Cipla on Tuesday said its consolidated net profit increased 30 per cent to Rs 1,222 crore in the fourth quarter ended March 31, 2025. Photograph: Danish Siddiqui/Reuters The......

Cipla

News for Cipla

'14+ Anti-Obesity Drugs In The Pipeline'

Cipla ready to partner in Covid vaccine distribution

Cipla gets nod to import Moderna vaccine for emergency use in India

Cipla to price Remdesivir for Covid-19 under Rs 5,000

Future Gaming tops electoral bonds list with Rs 1368 cr; who are the others?

Cipla Q2 profit up 3.7% at Rs 1,353 cr

Domestic sales a booster dose for pharma revenues

Weightloss Drugs Hit 1,000 Crore Mark

USFDA's new draft biosimilar rules to benefit Indian biotech cos

Cipla Q4 profit up 30% at Rs 1,222 cr

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS